Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activation.

Karagkouni D, Brake MA, Patell R, Falanga A, Marchetti M, Russo L, Mantha S, Neuberg D, Chiasakul T, Carrier M, Wells PS, Gerszten RE, Flaumenhaft R, Hui D, Vlachos IS, Schulman S, Zwicker JI

Open source

DOI
10.1126/scitranslmed.adu7160
Published
2026 Jun 17
Container
Science translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.adu7160,
  title = {Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activation.},
  author = {Karagkouni D and Brake MA and Patell R and Falanga A and Marchetti M and Russo L and Mantha S and Neuberg D and Chiasakul T and Carrier M and Wells PS and Gerszten RE and Flaumenhaft R and Hui D and Vlachos IS and Schulman S and Zwicker JI},
  year = {2026},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.adu7160},
  url = {https://doi.org/10.1126/scitranslmed.adu7160}
}

RIS

TY  - JOUR
TI  - Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activation.
AU  - Karagkouni D
AU  - Brake MA
AU  - Patell R
AU  - Falanga A
AU  - Marchetti M
AU  - Russo L
AU  - Mantha S
AU  - Neuberg D
AU  - Chiasakul T
AU  - Carrier M
AU  - Wells PS
AU  - Gerszten RE
AU  - Flaumenhaft R
AU  - Hui D
AU  - Vlachos IS
AU  - Schulman S
AU  - Zwicker JI
PY  - 2026
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.adu7160
UR  - https://doi.org/10.1126/scitranslmed.adu7160
ER  - 

APA

D, K., MA, B., R, P., A, F., M, M., L, R., S, M., D, N., T, C., M, C., PS, W., RE, G., R, F., D, H., IS, V., S, S., & JI, Z. (2026). Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activation.. Science translational medicine. https://doi.org/10.1126/scitranslmed.adu7160

Source records